Medical Communications

Showing 15 posts of 6402 posts found.

libtayo

Promising Phase 2 data for Sanofi and Regeneron’s PD-1 inhibitor Libtayo in locally advanced basal cell carcinoma

September 18, 2020 Medical Communications, Research and Development Cancer, ESMO 2020, Libtayo, Regeneron, Sanofi, pharma

Promising Phase 2 data has been released at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 for Sanofi …
800px-lt

Roche says its rheumatoid arthritis drug reduces the need for ventilators in coronavirus patients

September 18, 2020 Medical Communications COVID-19, Roche

Roche says that its Actermra/Roactemra drugs reduce the likelihood that coronavirus patients with virus-related pneumonia will need to be put …
256px-mikhail_murashko_2020-01-29

One in seven Russian COVID-19 vaccine recipients display side-effects, says Health Minister

September 18, 2020 Medical Communications, Research and Development COVID-19, Russia, Sputnik V, Vaccine

Around one in seven patients who have received Russia’s vaccine against COVID-19 have displayed side-effects in clinical studies, according to …
800px-jnjioffice

New York files $2 billion lawsuit against J&J for downplaying risks of opioids in its marketing

September 18, 2020 Medical Communications new york state, opioid crisis

New York State is suing Johnson & Johnson in a lawsuit seeking $2 billion in damages for the company’s role …
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

September 18, 2020 Medical Communications

The top ten news stories this week centre around coronavirus vaccines, with Russia signing a deal with an Indian pharma …
spotlighton-aprile-cw_covid-19-and-cancer-1-img

Oncology research in the age of COVID-19

September 14, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, pharma

Matt Fellows investigates the new challenges facing the oncology space and explores the strategies that can carry it through the disruptive …
james_caggiano

Targazyme snaps up new CEO

September 11, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targazyme, appointment

Experienced industry executive James Caggiano has been named as the new head of Californian biotech Targazyme, who will take up …
astrazeneca_sign_sky

NICE U-turns to approve AstraZeneca’s Tagrisso in two new lung cancer indications

September 11, 2020 Medical Communications, Sales and Marketing AstraZeneca, NICE, Tagrisso

NICE has announced the recommendation of AstraZeneca’s Tagrisso (osimertinib) for routine use on the NHS in England and Wales in …

Roche and Novartis fined a collective €444 million in France for abusive practices

September 11, 2020 Medical Communications eye medicine, eye treatment

Novartis and Roche have been fined €444 million in France for abusive practices the companies implemented to push Lucentis over …

NICE opts to reject Celgene’s Revlimid for newly diagnosed multiple myeloma after an autologous stem cell transplant

September 11, 2020 Medical Communications, Sales and Marketing Celgene, NICE, Revlimid

It has emerged that NICE has opted to reject Celgene’s Revlimid (lenalidomide) for the maintenance of newly diagnosed multiple myeloma …
fda_21

FDA sends warning letters to websites illegally selling opioids

September 11, 2020 Medical Communications

The FDA has issued warning letters to 17 websites for illegally selling unapproved or misbranded opioids.  This is due to …
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

September 11, 2020 Medical Communications COVID-19, coronavirus, vaccines

The top 10 news stories this week largely cover COVID-19 vaccines, as hundreds of thousands of people in China have …
bob_woodward_meets_with_edward_r

President Trump has misled the public on how deadly COVID-19 is, according to Watergate reporter’s tapes

September 10, 2020 Medical Communications All the President's men, Bob Woodward, Trump, Watergate

President Trump knew how much more deadly coronavirus was than the flu, despite public comments saying that the threat of …
steen-klysner-jpeg-1

Industry veteran Dr Steen Klysner appointed as Amarna’s new CEO

September 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amarna, appointments

Amarna Therapeutics has announced the appointment of a new Chief Executive Officer (CEO), hiring industry veteran Dr Steen Klysner to …
carter_percy

FibroGen names appointment for newly created Chief Scientific Officer role

September 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, fibrogen

FibroGen has created the new role of Chief Scientific Officer and appointed Dr Percy Carter to the position, it has …
The Gateway to Local Adoption Series

Latest content